Irbesartan Tablet
Product Images NDC 59746-449

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 59746-449). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jubilant Cadista Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

150mgbottle

150mgbottle
This is a description of medication called Irbesartan, which comes in the form of tablets. The usual dosage is not mentioned and the reader is urged to refer to the accompanying information. The medication is manufactured by Jubiant Generics L and distributed by Jubiant Cadista Pharmaceuticals Inc. The tablets contain 150mg of Irbesartan USP. The National Drug Code assigned to them is 59746-448-30. It is advised to store the medication in a container defined in the USP and away from children. The instructions suggest a temperature range for storage from 20°C to 25°C (68°F to 77°F), and to limit excursions from 15°C to 30°C (59°F to 86°F). Neutral code No is also mentioned.*
FDA Label Image

300mgbottle

300mgbottle
This appears to be a mixture of text fragments, symbols, and brand names. It is not possible to generate a useful description from this text.*
FDA Label Image

75mgbottle

75mgbottle
This is a medication label for a tablet containing 75 mg of Irbesartan. The tablet should be kept out of reach of children and stored in a closed container between 10-25°C (50-77°F) with permitted excursions to 1-30°C (69-85°F). The tablets are manufactured by Jubiant Gonorcs Lid and marketed by Jubiant Cadista Pharmaceuicas nc in Salisbury, MD, USA. The NDC number for this medication is 59746-447-30.*
FDA Label Image

Fig1

Fig1
The text describes two figures showing the placebo-subtracted reduction in trough SeSBP and trough SeDBP obtained from an integrated analysis of Irbesartan doses. The figures include a dose range of 150 to 900 mg/day. The rest of the text consists of some numbers and headings and is not useful for describing the figures.*
FDA Label Image

Figure3 (Figure3)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.